Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

Mitchell M. Levy,Marcel Levi,Mark D. Williams,Massimo Antonelli,Dazhe Wang,Mariano Alejandro Mignini

Comprehensive safety analysis of concomitant drotrecogin alfa (activated) and prophylactic heparin use in patients with severe sepsis

2009

Mitchell M. Levy
Marcel Levi
Mark D. Williams
Massimo Antonelli
Dazhe Wang
Mariano Alejandro Mignini

Purpose The safety of using heparin concomitantly with drotrecogin alfa (activated) {DrotAA} was explored in the XPRESS study. No heparin effect on mortality was observed. Safety results from that study are explored in more detail.

Keywords:

Clinical trial
Intensive care medicine
Heparin
Drotrecogin alfa
Anesthesia
Anticoagulant
Sepsis
Thrombolysis
Low molecular weight heparin
Concomitant
Medicine
intensive care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations